Skip to main content

Immunization Clinical Resources

The resources here supplement the BC Immunization Manual (Chapter 2: Immunization) in the BC Communicable Disease Control Manual.

Program updates & Q&As

These updates and Q&A documents support immunization service providers in British Columbia. The material is supplementary, and should be used as a complement to, the guidelines in the Communicable Disease Control Manual, Chapter 2: Immunization

The Q&A documents include the date of production. New information that reaches the public domain after the date of production is not incorporated. Practitioners must take responsibility for ensuring they have the most recent knowledge and are using the most recent guidelines relating to the situation with which they are dealing. 

COVID-19 Immunization Program

In December 2020, two COVID-19 vaccines (the Pfizer-BioNTech vaccine and the Moderna vaccine) were approved for use in Canada. BC's COVID-19 immunization program began in December, starting with priority populations based on the National Advisory Committee on Immunization (NACI) recommendations with the goal of preventing severe illness and death due to COVID-19. In the context of limited supply due to worldwide demand for COVID-19 vaccines, BC will prioritize populations to reduce their high risk of severe disease and death as much as possible, and to maintain our health care system’s capacity to take care of those who need health care services. As COVID-19 vaccine supply increases over the coming months, eligibility will expand to more population groups. For current information regarding the populations who are eligible to receive COVID-19 vaccine in BC refer to the Vaccine Eligibility page.

Tdap Vaccination During Pregnancy

Beginning November 2020, Tdap (tetanus, diphtheria and pertussis) vaccine will be provided free to people who are pregnant in every pregnancy. Vaccination is recommended at 27-32 weeks of gestation but it may be given from 13 weeks up to the time of delivery. The aim of this new program is to protect newborn infants in BC from severe outcomes related to pertussis infection. It is anticipated that Tdap vaccine will be provided mainly by prenatal care providers including family doctors and midwives, but can also be provided by specialty prenatal care service providers and by community-based pharmacists, or at the local health unit at adult immunization clinics.

Vaccine Status Reporting Regulation (VSRR)

Vaccine Status Reporting Regulation Information for Health Care Providers - Q&A (Jan 2020)

Part 3: Management of Anaphylaxis in a Non-Hospital Setting

At the direction of the B.C. Chief Nursing Officer Council a provincial decision support tool (DST) for the management of anaphylaxis, "Anaphylaxis: Initial Emergency Treatment by Nurses (Adult and Pediatric)" has been developed. The provincial DST was developed to ensure that the initial emergency management of anaphylaxis is consistent amongst all nurses across the province, in all settings. The provincial anaphylaxis DST is based upon the World Allergy Organization guidelines and has incorporated the most up-to-date evidence. The BC Immunization Manual, Part 3 - Management of Anaphylaxis in a Non-Hospital Setting has been revised to be consistent with the provincial DST.


Changes to the Rotavirus Immunization Program

Beginning May 2018 BC will begin transitioning to the use of pentavalent rotavirus vaccine (RV5, RotaTeq®) in the infant rotavirus immunization program. The main difference with this product change is the immunization schedule, as the schedule for RotaTeq® is 3 doses, rather than 2 doses of Rotarix®.  It is recommended that RotaTeq® be administered at 2, 4 and 6 months of age together with the other routine infant vaccines given at these ages.


Hepatitis A vaccine

HPV vaccines

INFANRIX vaccines

Influenza vaccines

MMRV vaccine

Meningococcal vaccine

Pneumococcal conjugate (PCV13) vaccine

Rotavirus vaccine

Varicella vaccine


Immunization schedules

Routine schedules

Children and adults may benefit from additional vaccines that are not included in the BC routine immunization schedules. For more information, see:

For complete guidelines, see the BC Immunization Manual, Part 1: Immunization Schedules 

Immunization record cards

MSP billing codes

Adverse events following immunization

For resources, see Adverse Events Following Immunization

For complete guidelines, see the BC Immunization Manual, Part 5: Adverse Events Following Immunization

Informed consent for immunization

For resources, see Informed Consent for Immunization

For complete guidelines, see the BC Immunization Manual, Appendix A: Informed Consent for Immunization 

Vaccine administration

Injection sites

Intranasal route (Flumist vaccine only)

For complete guidelines, see the BC Immunization Manual, Appendix B: Administration of Biological Products

Immunization forms & letters

Immunization communication

Immunizer education videos

SOURCE: Immunization Clinical Resources ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Centre for Disease Control. All Rights Reserved.

    Copyright © 2021 Provincial Health Services Authority.